Pacira BioSciences, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Pacira BioSciences, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2023.
  • Pacira BioSciences, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$2.82M, a 98.2% increase year-over-year.
  • Pacira BioSciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$183M, a 54.4% increase from 2022.
  • Pacira BioSciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$402M, a 205% decline from 2021.
  • Pacira BioSciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $381M, a 71.2% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$183M +$218M +54.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$402M -$782M -205% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $381M +$158M +71.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $222M +$219M +5957% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $3.67M -$5.28M -59% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $8.95M -$215M -96% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $224M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.